Title

Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura

Document Type

Article

Publication Date

2009

Abstract

To report on the efficacy of rituximab (RTX) therapy in standard treatment-refractory, chronic Henoch-Schönlein purpura, a retrospective chart review of 3 pediatric patients treated with RTX for severe refractory chronic Henoch-Schönlein purpura was performed. All 3 patients responded to 1 or 2 courses of RTX without serious adverse events.

DOI

10.1016/j.jpeds.2008.12.049

PMCID

19559299

Find in your library

Off-Campus WSU Users


Share

COinS